Chewable Versus Regular Carbamazepine

J Gordon Millichap

doi:10.15844/pedneurbriefs-6-7-6

Chewable Versus Regular Carbamazepine

Pediatric Neurology Briefs

Volume 6 (1992): Issue 7

By: J Gordon Millichap

Open Access

|Jul 1992

Abstract

A comparison of chewable and regular carbamazepine (CBZ tablets) in 44 children receiving chronic CBZ monotherapy is reported from the IWK Children’s Hospital, Halifax, Nova Scotia.

References

Camfield P Hwang P Camfield C Fraser A Soldin S al-Quadah AK The pharmacology of chewable versus regular carbamazepine in chronically treated children with epilepsy Can J Neurol Sci 1992 May 19 2 204 207 1623447
Search in Google Scholar Back to article
Oles KS Penry JK Smith LD Anderson RL Dean JC Riela AR Therapeutic bioequivalency study of brand name versus generic carbamazepine Neurology 1992 Jun 42 6 1147 1153 10.1212/WNL.42.6.1147 1603340
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-6-7-6 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 52 - 53

Published on: Jul 1, 1992

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Chewable,

Regular Carbamazepine,

Pharmacokinetics

© 1992 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 6 (1992): Issue 7